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Background: In Low and Middle Income Countries, mental health services are often poorly developed due to the
lack of resources and trained personnel. In order to overcome these challenges, new ways of care have been
suggested such as a focus on community-based services. In Somalia, the consumption of the natural stimulant khat
is highly prevalent, aggravating mental illness. At the same time, mental health care is largely unavailable to the
vast majority of the population. In a pilot project, we tested possibilities for effective measures in community-based
out-patient mental health care.
Methods: Thirty-five male patients with chronic psychotic disorders and their carers were involved in a 10-months
follow-up study. All of them abused khat. Seventeen outpatients experiencing acute psychotic episodes were
recruited from the community and received an intensive six week home-based treatment package. Additionally
eighteen patients with chronic psychotic disorders in remission were recruited either following hospital discharge
or from the community. In a second phase of the study, both groups received community-based relapse
prevention that differed in the degree of the family’s responsibility for the treatment. The treatment package was
comprised of psycho-education, low-dose neuroleptic treatment, monthly home visits and counseling. The Brief
Psychiatric Rating Scale (BPRS) was applied three times. Additionally, we assessed functioning, khat use and other
outcomes.
Results: Of the 35 patients enrolled in the study, 33 participated in the 10-month follow-up. Outpatients improved
significantly in the first six weeks of treatment and did not differ from remitted patients at the start of the second
treatment phase. In the preventive treatment phase, we find heterogeneous outcomes that diverge between
symptom and functioning domains. With the exception of depressive symptoms, symptoms in all patients tended
to worsen. The outpatient group had higher BPRS positive and negative symptom scores compared to the remitted
group. Levels of functioning in 20 out of 33 patients significantly improved, with small differences between groups.
Most patients experienced improvements in basic functioning, such as communication, self-care etc. Khat use could
only be reduced in the group of outpatients.* Correspondence: michael.odenwald@uni-konstanz.de
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demonstrated positive effects in Somalia and is both feasible and practical, despite facing formidable challenges,
e.g. controlling khat intake.
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Mental disorders are responsible for a large proportion
of the global burden of diseases and premature deaths
[1,2]. Especially in Low and Middle Income Countries
(LMIC) where psychiatric services are poorly developed,
there is a large treatment gap [3,4] and consequently a
high burden of mental illnesses [5]. Chronic psychotic
disorders constitute a group of disorders with especially
high costs to individuals, families, communities and so-
cieties alike [6-8], especially in LMICs where the course
and outcomes of the disorder remain debilitating [9,10].
In LMICs, mental health services are short staffed and
often poorly developed [11]. High mortality rates among
people with mental illnesses [9] are common and care-
givers resort to inhumane practices such as forcible re-
straint [12].
Recently mental health experts have recommended new
methods of mental health care in LMICs that are adapted
to the local needs and resources, e.g. involvement of non-
psychiatric staff, non-medical staff (e.g. nurses), and low
dose neuroleptic treatment in the community [13,14]. In
spite of initial attempts to implement community-based
or non-specialist care for schizophrenia [15-17] the imple-
mentation keeps facing huge challenges [3,18-20].
After several decades of civil war as well as repeated
drought and famine, Somalia is one of the world’s
poorest countries and sadly holds the record on the
Failed State Index [21]. The former British protectorate
Somaliland declared independence in 1991, becoming
the Republic of Somaliland and, although not inter-
nationally accepted, has developed with increasing sta-
bility in contrast to the rest of the country. We have
observed high rates of chronic psychotic disorders
among men in Somaliland and documented that the ma-
jority of these patients have a history of khat abuse [12].
Despite the elevated prevalence of psychotic and other
mental disorders amongst the two to three million inha-
bitants [22], there are only a few providers of mental
health services, each of which is understaffed and under-
resourced [22,23]. The specific challenges of building a
health care system in Somaliland have recently received
some attention [24].
Khat leaves (khat; catha edulis) have been traditionally
consumed in the countries around the Horn of Africa and
are today the most commonly abused substance inSomalia. During the past 30 years, khat has had an enor-
mous boom and its use dramatically increased in Somalia
[25] while traditional social regulation mechanisms simul-
taneously eroded [26]. The principal agent cathinone is an
amphetamine-like alkaloid [27] and was recently asso-
ciated with compulsive use and addiction [28]. Excessive
khat use can elicit psychotic symptoms and reactions
[29,30]. Other mental disorders can increase the use of
khat as means of self-medication with an increasing dan-
ger of psychotic developments [29,31]. In our previous
cross-sectional studies of psychosis in Somalia, early onset
of khat use and excessive use were retrospectively asso-
ciated to the development of chronic psychosis [12].
Bimerew and colleagues found that khat use is related to
the relapse of previously diagnosed schizophrenia [32].
In the present study, we piloted the implementation of
different components of a community-based treatment
study for patients with chronic psychotic disorders in
Somalia: an acute treatment package and two variants of
preventive long-term treatment. As all of the psychotic
patients were khat users, additional consideration was
given to co-morbid disorders. This co-morbidity reflects
that in Somalia most men, particularly male psychotic
patients, abuse khat [12]. The following research ques-
tions were asked: Is a home-based psychiatric treatment
including neuroleptics feasible when implemented by
paramedics lacking psychiatric expertise? Is a treatment
implemented by paramedics ethically justifiable or even
required, vis a vis a common practice of hog-tying
humans? Is it possible for a community-based treatment
program without hospital support to effectively reduce
psychotic symptoms and improve functioning in patients
who abuse khat? Can khat use be controlled among se-
verely psychotic patients being treated in the commu-
nity? Providing answers to these questions allows the
development of innovative concepts for large-scale men-
tal health service delivery, the identification of important
factors that determine success and break ground for
more extensive studies in the future.
We hypothesized that symptom severity can be signifi-
cantly reduced within six weeks among acutely psychotic
patients by receiving treatment exclusively within the
community. Furthermore, we predicted that in the two
models of continued psychiatric care for remitted
patients, low symptom levels can be maintained, levels
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over a period of ten months. Primary outcome measures
included psychiatric symptom levels, every-day function-
ing and khat use; secondary outcome measures included
Body Mass Index, medication side effects, medication
compliance, restraint and the use of other mental health
treatments during the project period.
Methods
Design
In this intervention study, we followed up with two groups
of male patients with chronic psychosis and their families:
acute psychotic patients exclusively treated in their fam-
ilies within the community (from hereon named “outpati-
ents”; N= 17) and patients with remitted psychosis (from
hereon named “remitted patients”, N= 18) that were
recruited either from the community (N=7) or at dis-
charge from inpatient treatment (N=11). In the first
phase of the study (acute treatment) only outpatients were
involved, and we compared within symptom changes from
pre to post acute treatment (six weeks). In the second
phase of the treatment (relapse prevention), we compared
the effect of continued psychiatric care in outpatients and
remitted patients. In this phase of the study, outpatients
received continued psychiatric care exclusively during
home visits (outpatients) while for remitted patients, after
an initial contact through service providers (e.g. inpatient
services) home visits were designed to establish active re-
sponsibility of patients and their carers for medication
intake (see Figure 1). We report data from three assess-
ments: in April or May 2006 (T1), before inclusion into
phase one of the study; six weeks later, in June or July
2006 (T2), after the first six weeks of acute outpatient
treatment. At this point (T2), remitted patients entered
the study (i.e. first assessment for remitted patients); and
ten months later (T3), in March or April 2007(bothFigure 1 Design of the study.groups; see Figure 1). Outcomes of later follow-up assess-
ments will be reported elsewhere.
Participants
In total, 41 male patients were approached and six
patients could not be included in the project because
other neurological or psychiatric disorders did not allow
a neuroleptic treatment (N = 2) or patients and their
carers refused to cooperate (N = 4). The outpatient
group was recruited from the community and consisted
of 17 patients with chronic psychotic disorders not
receiving psychiatric treatment and experiencing an ac-
tive illness episode. The second group comprised 18
patients who also suffered from chronic psychotic disor-
ders that were in remission at that time: 11 patients were
recruited at discharge from psychiatric in-patient treatment
and 7 psychotic patients currently in remission who were
recruited in the community and who currently did not re-
ceive any in-patient treatment. Patients who were recruited
in the community were participants of an earlier cross-
sectional study [12]. All patients fulfilled DSM-IV criteria
A, B and C for Schizophrenia [33].
Socio-demographic characteristics are reported in Table 1.
Both groups were comparable in all variables but Body
Mass Index; patients recruited in the community were mal-
nourished at the project start. In both groups we found very
high levels of khat addiction (previous year) and an early
age of khat use onset.
In Table 2, illness-related information is presented. On
average, disruptive psychotic symptoms had emerged
at the age of 24 years and the illness persisted for over
10 years. Outpatients had fewer episodes of in-patient
treatment and their last hospital stay was longer ago
than among remitted patients. Both groups had equally
consulted different institutions for treatment, i.e. western-
trained medical doctors, traditional healers (working with




Total (18) Discharged (11) Community (7)2
Age 36.5 36.4 38.2 33.7
(9.8) (8.0) (8.0) (7.7)
Years of education2 6.9 5.6 4.9 6.6
(5.0) (5.3) (5.7) (5.0)
Rating of economic situation index3 1.3 1.6 1.1 2.3
(1.1) (1.0) (0.9) (0.8)
Objective index of economic situation4 1.9 2.1 1.7 2.8
(1.0) (1.2) (1.2) (0.8)
Number of household members5 8.5 7.1 6.6 7.8
(3.0) (3.9) (4.1) (2.9)
Currently married6 12% 33% 46% 14%
(2) (6) (5) (1)
Refugee experience7 65% 69% 89% 43%
(11) (11) (8) (3)
Combat exposure7 29% 44% 56% 29%
(5) (7) (5) (2)
BMI at project start8 16.9 19.7 20.7 17.6
(3.5) (2.9) (3.1) (1.2)
Lifetime khat use7 94.1% 100% 100% 100%
(16) (17) (10) (7)
Age of onset of khat use9 15.8 17.3 17.1 17.6
(4.6) (4.1) (4.2) (4.2)
Khat addiction (last year)10 70.0% 93.3% 100% 80.0%
(7) (14) (10) (4)
Lifetime Alcohol use4 5.9% 18.8% 33.3% 0%
(1) (3) (3) (0)
Remitted patients comprise patients recruited at hospital discharge and in the community. The table reports means and standard deviations as well as
percentages and N.
2 missing data: 17 outpatients, 17 remitted patients (10 discharged, 7 community).
3 missing data: 16 outpatients, 16 remitted patients (10 discharged, 6 community).
4 missing data: 17 outpatients, 16 remitted patients (10 discharged, 6 community).
5 missing data: 15 outpatients, 17 remitted patients (11 discharged, 6 community)
6 patients currently married as opposed to a composed category of being single, separated, divorced or widowed.
7 missing data: 17 outpatients, 16 remitted patients (9 discharged, 7 community).
8 missing data: 15 outpatients, 12 remitted patients (8 discharged, 4 community).
9 missing data: 15 outpatients, 17 remitted patients (10 discharged, 7 community).
10 missing data: 10 outpatients, 15 remitted patients (10 discharged, 5 community).
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Both groups had experienced inhumane ways of managing
mental illness common for regions without access to
medical treatment (e.g. being imprisoned, chained, i.e.
hog-tied, or locked up; for details see Table 2).
Diagnostic process, measurement and instruments
In order to ensure the existence of a chronic psychotic
disorder, items from the WHO’s Composite Inter-
national Diagnostic Interview, psychosis part [34] were
used at study entry. Additionally illness-related informationwas gathered in interviews with carers. Before study entry,
khat addiction was assessed using the MINI International
Neuropsychiatric Interview [35]. Several studies have docu-
mented that khat users can develop khat-related depen-
dence syndrome [36,37].
At pre-, post- and follow-up test the Expanded Brief
Psychiatric Rating Scale [38,39] was conducted to quantify
the severity of related symptom clusters. This interview is
a frequently used instrument with good psychometric
properties. Besides the total score (all 24 items), we ana-
lyzed subscales based on the extensive study by Velligan




Total (18) Discharged (11) Community (7)
Age at psychosis onset 22.8 (7.3) 25.4 (6.2) 27.4 (6.3) 22.3 (4.9)
Duration of illness 13.6 (5.2) 11.0 (6.4) 10.7 (6.2) 11.4 (7.1)
Times treated in Mental Hospital 0.9 (0.9) 2.3 (2.7) 2.7 (3.3) 1.6 (1.1)
Last discharge from Mental Hospital: years ago2 3.2 (2.6) 1.0 (2.8) 0 (0) 3.2 (4.6)
Times consulted a medical doctor3 0.9 (1.1) 0.7 (0.8) 0.3 (0.5) 1.3 (1.0)
Times consulted a traditional healer4 1.7 (3.2) 1.9 (2.0) 2.3 (2.2) 1.4 (1.8)
Times consulted a sheikh5 1.6 (2.3) 1.2 (1.3) 1.7 (1.5) 0.6 (0.5)
Times admitted to prison due to mental problems6 1.8 (3.5) 0.9 (2.0) 0.9 (1.9) 1.0 (2.5)
Months of life locked up due to mental problems7 4.0 (14.6) 1.0 (3.6) 1.7 (4.6) 0.1 (0.0)
Months of life chained (hog-tied) due to mental problems8 57.8 (96.7) 15.9 (27.9) 4.1 (5.5) 32.9 (38.3)
Remitted patients comprise patients recruited at hospital discharge and in the community. The table reports means and standard deviations as well as
percentages and N.
2only includes patients with a psychiatric inpatient history: 9 outpatients, 16 remitted patients (11 discharged, 5 remitted).
3missing data: 17 outpatients, 17 remitted patients (10 discharged, 7 community).
4missing data: 17 outpatients, 16 remitted patients (9 discharged, 7 community).
5missing data: 17 outpatients, 16 remitted patients (9 discharged, 7 community).
6missing data: 17 outpatients, 16 remitted patients (10 discharged, 6 community).
7missing data: 17 outpatients, 15 remitted patients (9 discharged, 6 community).
8missing data: 16 outpatients, 17 remitted patients (10 discharged, 7 community).
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(items: Unusual Thought Content, Hallucinations, Con-
ceptual Disorganization, Bizarre Behavior, Cronbach’s
Alpha .67), Negative Symptoms (Blunted Affect, Psycho-
motor Retardation, Emotional Withdrawal, Alpha .79),
Depression/Anxiety (Depression, Anxiety, Guilt, Suicidality;
Alpha .78), Activation (Excitement, Tension, Mannerisms
and Posturing, Motor Hyperactivity; Alpha .68). In order to
improve the legibility, we subtracted 1 from the original
BPRS values. Structured clinical interviews were conducted
by a trained senior psychiatrist (WP) and a trained senior
psychologist (MO).
Before inclusion into the project we assessed whether
the patient had ever used khat in his life. In every inter-
view, we assessed khat use in the month prior to the
interview as a categorical variable. Additionally, we
quantified khat use in the week prior to the interview by
days with khat use and by the amount of consumed
traded units (bundles). We also used a simple amphet-
amine quick test (immunochromatographic assay) to de-
termine the existence of khat alkaloids in the urine
(Oekonomed, Darmstadt, Germany). The test has been
evaluated for khat alkaloids in a previous study [41].
Despite the varying potency of khat samples and the limited
comparability of bundles, there is currently no other feas-
ible method to retrospectively quantify khat use [31]. This
kind of test is considerably cheap (approximately half a
dollar per test stripe) which is a prerequisite for the applica-
tion in a Low Income Country.
At T3 we asked carers to generally rate whether the
patients had improved in different domains of everydayfunctioning since inclusion into the project. In order to
validate these yes-no questions, we additionally asked
them to mention and describe activities of daily life in
which they felt the patient had improved and behaves
the way a healthy individual would (for example, talking
to others, personal hygiene). For each activity we asked
for the number of days in the previous week the patient
demonstrated this improved behavior. Furthermore, we
asked them on how many days per week the patient had
behaved like this one year ago before the start of the
project. We report the number of activities that had
improved and the average number of days that had
improved, i.e. the difference between last week and be-
fore project start. In order to estimate the validity of this
assessment of functioning, we used data recorded from a
different study. Carers’ functioning ratings were summed
up by adding up all days last week functioning “as a
healthy individual” over the different domains reported
here; this sum scale achieved a moderate reliability
(Cronbach’s Alpha .677). The sum scale correlated nega-
tively with the total number of days hog-tied in the
month before (−.489, p = .006), evincing that we have
validly assessed levels of functioning.
Additionally, we assessed medication compliance (days
without medication in the previous month), the way of a
family’s management of patients in the last month
(chaining, i.e. hog-tying, locking up) and treatment seek-
ing behavior (consultation of traditional healers, reli-
gious healers and western trained medical doctors).
Before inclusion into the project we quantified lifetime
experience of being restrained due to mental problems
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persons with mental illness and aggressive behaviors are
frequently brought to prison by their families as an attempt
to prevent offenses. As a measure for patients’ physical con-
dition we used the BMI.
The economic situation of a household was rated using a
five-point Likert scale (very poor, poor, moderate, good,
very good). Additionally the wealth was assessed with a
method reported by Odenwald et al. [12]. The sum of four
significant household assets (electricity, water tap, TV set,
car) and the house type (hut= 1, corregated iron=2, brick
house=3, closed compound=4) was assessed. The average
served as indicator for the economic situation. This rating
achieved a good realibility (Cronbach's Alpha=0.78) and a
high correlation with income (0.73, p <0.001; [12]).
Psychosocial care and medication
All patients included in the project received a free treat-
ment package including neuroleptic medication. They
were first offered low-dose neuroleptic treatment with
Chlorpromazine (CPZ) as recommended by the WHO
[42]. This substance was chosen based on an assessment
of prescriptions in the Hargeisa Group Hospital psychi-
atric ward and of a local market survey before project
start: CPZ proved to be the standard neuroleptic treat-
ment in Somaliland and the only neuroleptic drug with
an uninterrupted supply on the local market; its price
proved to be stable on a low level, which is important
for sustainability, as it might be necessary to continue
the treatment beyond the duration of the project. Treat-
ment was changed to low-dose Haloperidol in case CPZ
was not tolerated.
Prescriptions were made on the basis of the diagnostic
interviews and when available on medical records and
information from the Hargeisa Group Hospital staff. For
the discharged patients, after a thorough examination by
a senior psychiatrist (WP), the hospital treatment regi-
men was adjusted when necessary and continued.
Patients without any active illness process who were cur-
rently off any medication were offered preventive long-
term treatment with very low doses. The average CPZ
dose prescribed was with an average of 115 mg low
(Table 3) in order to minimize side effects in the absenceTable 3 Treatment delivery of the project
Outpatien
No of home visits in 1st 6 weeks after inclusion into the project 4.5 (2.1)
Prescricption of Chlorpromazine (mg) 122.1 (49.9
Prescription of additional Biperidene 41% (7)
Prescription of additional Promethazine 35% (6)
The table reports means and standard deviations as well as percentages and N.
1comparison of outpatients and remitted patients.of an intensive psychiatric monitoring during the project
phase. Adjunct treatment with Promethazine (9) or
Biperidene (8) was prescribed when necessary. After
follow-up, in two patients the neuroleptic treatment had
to be changed to Haloperidol (2 mg/day) due to side
effects (1) and missing effectiveness (1). All drugs were
provided by the project and made available free of
charge to the patients. A local general practitioner was
contracted to be available during the project period in
the case of arising questions concerning medication, side
effects and co-morbid medical problems. Regular online
supervision by senior researchers with local staff mem-
bers assured that questions arising from home visits
could be discussed and resolved.
Treatment delivery
At the time of inclusion into the project, both groups
received repeated home visits by international research
staff for confirmation of diagnosis, prescriptions of psy-
chopharmacological drugs and instruction on the pro-
ject. The acute treatment phase of the project involved
only the group of outpatients. In the acute treatment
phase, team members carried out a total of 77 home vis-
its for diagnostic interviews, prescription and adjustment
of medication by an experienced psychiatrist (see
Table 3). In case additional medical problems emerged,
patients and their carers were offered assistance to find
adequate medical treatment. In this first treatment
phase, families and patients received intensive informa-
tion on the negative effects of khat use on psychotic dis-
orders; special emphasize was put on motivation to stop
using khat. T2 was the posttest for outpatients and mea-
sured the effect of the acute treatment in this group. T2
was the first assessment of remitted patients, who
entered the study in a low-symptom phase of their ill-
ness, and marked the beginning of the preventive phase
of treatment. Remitted and outpatients were enrolled in
the second, preventive treatment phase of the study. At
the time of inclusion into the study, remitted patients
received a total of 41 home visits for diagnostic inter-
views and continuation of prescription.
In the second phase of the study, outpatients and
remitted patients received a total of 196 home visits byts (17)
Remitted patients p1
Total (18) Discharged (11) Community (7)
2.3 (1.1) 2.6 (1.0) 1.9 (1.2) <.001
) 105.6 (80.2) 145.5 (68.8) 42.9 (53.5) .473
6% (1) 9% (1) 0% (0) .018
17% (3) 27% (3) 0 (0) .264
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were the central element of the treatment packages deliv-
ered to both groups. The home visits in both groups
included the monitoring of symptoms and side effects,
repeated psycho-education, motivation to adhere to the
prescribed treatment, the discussion of current problems,
active listening to the carers’ and patients’ problems and
emotional support. Local research staff was also instructed
to motivate patients and carers of both groups to stop using
khat.
Additionally, the two treatment packages differed
in important aspects. Outpatients and their carers
had a much lower responsibility for their medication
treatment as compared to remitted patients and their
carers. Outpatients received the prescribed drugs
during home visits by the staff of our partner NGO.
This implied that a very close monitoring of medica-
tion intake took place, i.e. tablets were counted
precisely and the prescription regimen was explained
and discussed in detail during every home visit
with both carers and patients. Non-compliance was
noticed early and team members tried to convince
patients and carers or supported carers to improve
the patient’s compliance. In case of emerging side
effects team members assisted by consulting with the
supervising psychiatrist (online supervision) and were
able to adjust doses or start with adjunct treatment.
On a monthly basis, remitted patients and their carers
were responsible for obtaining their medication from a
location several kilometers from home. The group of
discharged patients received their medication on a
monthly basis from the hospital dispensary where had
been treated before and where they had to wait in long
lines during opening hours; the remitted community
patients were asked to collect their medication from the
office staff of our local partner NGO (not from the social
workers who did the home visits). The reason for this
type of medication delivery was the observation that it is
beneficial for patients and their families to maintain con-
tacts to the institution that provided in-patient care. As
a consequence of this different form of medication deliv-
ery, after briefly asking for whether problems with medi-
cation existed, home visits among remitted patients were
mainly focused on other topics and were much shorter.
In the case of most remitted patients our partner NGO’s
staff was not aware of the exact extent of problems with
medication compliance.
In our observation, treatment delivery different
also in the following aspects: In the outpatient group
home visits were much longer and more intense.
Because only outpatients participated in the acute
treatment phase, the relationships that developed
between project staff, patients and carers were more
intensive.Ethical approval
Prior to inclusion into the project, patients and their
carers were fully informed about the project and were
asked to give their written informed consent to par-
ticipate in the project. We especially highlighted that
benefits related to the project were exclusively psychi-
atric treatment to the patient and psycho-social assis-
tance to the patient and the carer and NOT economic
support.
All procedures had been approved in 2006 by the
University of Konstanz Institutional Review Board. Add-
itionally, the project was approved by the Somaliland
Ministry of Health and Labour and the National Health
Research Ethical Committee.
Statistical analysis
Changes of single variables over time were tested using
paired t-tests. For testing changes of psychotic symptoms
over the various assessments we performed repeated mea-
sures ANOVA for the group of outpatients and remitted
patients separately. We report Greenhouse-Geisser cor-
rected values whenever the sphericity assumption was
violated.
We compared the two patient groups using Students
t-test (or Mann–Whitney test in case preconditions were
not fulfilled) and chi2 test (or Fisher’s exact test if precondi-
tions were not fulfilled). If not otherwise reported, a One-
Way-ANOVA (or Kruskal-Wallis test if preconditions were
not fulfilled) comparing outpatients with the two subgroups
of remitted patients (discharged, community patients) and
Scheffe’s post-hoc tests (or Mann–Whitney if preconditions
were not fulfilled) did not reveal significant differences.
Results
At follow-up, 33 of our 35 patients could be traced and
re-interviewed (17 outpatients and 16 control patients).
Side effects
According to the ratings of patients and their carers at fol-
low-up, most patients (87%) experienced side effects of the
psychiatric medication; the number of patients reporting
any side effects did not differ between the groups (p= .613).
These side effects were usually tolerable and the contracted
medical doctor did not need to be consulted in any case of
side effects. Severity did not differ between outpatients and
remitted patients (see Additional file 1: Table S1; p= .794).
In total, 40% (12) of the patients experienced side effects
that were rated severe, this was mostly sedation, increased
saliva production and dyskinesia; the prevalence of severe
side effects did not differ between groups (.547).
Medication compliance, other treatments and restraining
According to carers, 63% of patients always took
their medication voluntarily during the project (12/
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the last month before follow-up, 61% of patients
were compliant with medication (13/17 outpatients
vs 7/16 remitted patients, p = .055). We found a
strong trend that outpatients were compliant to pre-
scribed medication on more days in the month
before follow-up interview than remitted patients.
The former did not take medication for on average
6.5 days (SD 10.9) while the latter for 14.9 days (SD
13.8; p = 0.058).
At the time of inclusion into the project, ten patients
were chained in their homes, six of them in the group of
out-patients, four among remitted patients (p = .708).
We found that chaining of remitted patients was a com-
mon practice especially in situations in which families
did not fully trust in the patients’ symptom stability and
khat abstinence. At the time of the follow-up interviews,
eight patients were chained, five of them among the out-
patients and three among remitted patients (p = .688).
Compared to project start, we found at follow-up one
patient had been newly chained and three were released.
During the follow-up period, six of the ten patients
chained at project start and one other patient who had
been newly restrained had been repeatedly released and
re-restrained; this circle of chaining, release and re-
restraining happened up to 5 times, on average one time
per participant; outpatients and remitted patients were
equally often ever restrained during the project.
On average, study participants remained restrained at
their homes for 60.1 days (SD 113.6) during the second
project phase; outpatients and remitted patients did not
differ in this respect (116.9 days SD= 28.4 vs 113.9 days,
SD= 29.4; p = .939; patients not having been chained
excluded).
Four remitted patients and none of the outpatients
were admitted for in-patient treatment to the psychiatric
ward of the Hargeisa Group Hospital during the follow-
up period (p = .044). Average length of stay was 35.6 days
(SD 73.7, range 60–240 days); all of them were still hos-
pitalized at the time of follow-up interviews.
During the follow-up period ten patients contacted a
medical doctor because of psychiatric problems, three
among the outpatients and seven among the remitted
patients (p = .259). On average, patients spent 1.1 US$
(SD 2.8) for these medical treatments, ranging from 0 to
10 US$ per consultation; there were no differences be-
tween outpatients and remitted patients (0.88 US$, SD
2.6 vs 1.3 US$, SD 3.1; p = .647).
During follow-up five patients contacted traditional hea-
lers or sheikhs, two in the remitted group, three in the
outpatient group (p= 1.000) and spent between 40 and
100 US$ per consultation. On average, patients spent 10.9
US$ for their treatments (SD 28.0); outpatients spent on
average 14.1 US$ (SD 33.8), remitted patients 7.5 US$ (SD20.8; p = .506). Between those patients who had contacted
a sheikh or healer and those who did not, no statistical sig-
nificant differences regarding days without medication in
the month before the follow-up interview emerged (16.6
days, SD 15.4 vs 9.3 days, SD 12.3; p = .448).
Nineteen of the study participants did not search for
assistance outside to what was offered from the project,
while 15 did (four participants were receiving additional
assistance from two types of services); outpatients and
remitted patients did not differ regarding any contact
with service providers outside the project (p = .119) and
number of different service providers approached (0.35,
SD 0.61 vs 0.75, SD 0.77; p = .110).
BMI
At the time of inclusion into the study, 21 patients had a
BMI below 20 and 9 below 16. At that point in time, the
BMI of outpatients was significantly lower than that of re-
mitted patients (p= .039; see Table 1). This difference was
due to lower BMI in all patients recruited in the commu-
nity. At follow-up, no difference could be detected any more
(outpatients: M=19.3, SD=3.6; remitted patients: M=21.2,
SD=2.7; p= .123). In both groups, significant increases of
the BMI were detected from pre-enrollment to follow-up
assessment (p= .001, p= .008). At follow-up, 14 patients
remained with a BMI below 20, but only 2 below 16.
Changes in symptom severity
Outpatients initially had a moderate to severe psychotic
symptom profile (Table 4). Before the inclusion into the
acute treatment phase we found a moderate correlation
of khat use as measured by the urine test to BPRS
subscale Positive Symptoms (.430, p = .085, n = 17).
Correlations to other BPRS scales were much smaller
(r < = .296, p > = .266).
After the first six weeks of treatment in their families,
symptom levels of outpatients had significantly improved
(p < .001 for all BPRS scales; see Table 4), reaching the
level of the remitted patients, i.e. no significant differ-
ences in all BPRS scales between the two groups (see
Table 4; Figure 2). Remitted patients who entered at this
stage into the study showed negative correlations be-
tween the khat urine test and BPRS scales (Total -.460,
p = .073, Positive -.358, p = .174, Negative -.573, p = .020,
Depression -.427, p = .099; N = 16).
In the follow-up assessment, symptom severity had
increased in both groups as indicated by significant higher
BPRS scales. Comparing the different BPRS scales using
repeated measures ANOVA, the deterioration of symptoms
in both groups at follow-up compared to T2 emerged in
the Total scale, the Positive Symptoms and Negative Symp-
toms subscales but not in the Depression/Anxiety subscale
where improvements could be maintained (see Table 4).
This deterioration was more pronounced in the outpatient







BPRS Total Pre 1.43 (0.59) - -
Post 0.27 (0.47) 0.43 (0.38) .273
Follow-up2 1.47 (0.69) 0.90 (0.67) .021
Repeated measures ANOVA p <.0013 <.0014 -
Contrasts Pre-Post: <.001 - -
Pre-FU: .816
Post-FU: <.001
BPRS Positive Pre 1.70 (1.05) - -
Post 0.36 (0.63) 0.32 (0.51) 0.823
Follow-up2 1.81 (1.47) 0.89 (1.15) .054
Repeated measures ANOVA p <.0015 .0276 -
Contrasts Pre-Post: <.001 - -
Pre-FU: .791
Post-FU: .001
BPRS Negative Pre7 1.56 (0.83) - -
Post 0.32 (0.68) 0.37 (0.46) .812
Follow-up2 2.89 (1.71) 1.42 (1.13) .024
Repeated measures ANOVA p <.0018 <.0019 -
Contrasts Pre-Post: <.001 - -
Pre-FU: .022
Post-FU: <.001
BPRS Depression Pre7 2.06 (1.43) - -
Post 0.34 (0.70) 0.64 (0.47) .144
Follow-up2 0.50 (0.79) 0.65 (0.60) .562
Repeated measures ANOVA p <.00110 .97411 -
Contrasts Pre-Post: <.001 - -
Pre-FU: <.001
Post-FU: .551
BPRS Activation Pre12 1.44 (0.72) - -
Post13 0.49 (0.58) 0.38 (0.52) .684
Follow-up2 0.90 (1.12) 0.70 (0.94) .595
Repeated measures ANOVA p .00714 .44415 -
Contrasts Pre-Post: <.001 -
Pre-FU: .051
Post-FU: .120
The table reports means and standard deviations of different BPRS scales and outcomes of within-group as well as between-group comparisons.
1comparison of outpatients and remitted patients.
2missing data: 17 outpatients, 16 remitted patients (10 discharged, 6 community).
3repeated measures ANOVA: df = 2, F = 32.252.
4repeated measures ANOVA: df = 1, F = 42.780.
5repeated measures ANOVA: df = 2, F = 10.308.
6repeated measures ANOVA: df = 1, F = 6.031.
7missing data: 16 outpatients.
8repeated measures ANOVA: df = 1.260, F = 18.428.
9repeated measures ANOVA: df = 1, F = 20.950.
10repeated measures ANOVA: df = 2, F = 20.757.
11repeated measures ANOVA: df = 1, F = 0.001.
12missing data: 10 outpatients.
13missing data: 17 outpatients, 6 remitted patients (4 discharged, 2 community).
14repeated measures ANOVA: df = 2, F = 6.629.
15Repeated measures ANOVA: df = 1, F = 0.771.














































































































outpatients (N = 17)
remitted patients (N = 18)
Figure 2 Development of psychotic symptom severity during the project. We report BPRS scales for the different assessment times. Bars
represent means and standard deviations. In order to improve the legibility we subtracted 1 from original BPRS values.
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greater BPRS Total, Positive and Negative Symptom scores
compared to remitted patients (see Table 4). At follow-up,
we found negative correlations between the khat urine
test and BPRS scales without differences between groups
(Total -.419, p= .019, Positive -.467, p= .008, Negative
-.029, p= .878, Depression, -.266, p= .156, Activation, -.197,
p= .288; N=31).
Improvement in every-day functioning
Our second primary outcome measure for treatment
success was the improvement in every-day functioning
(Table 5). In the opinion of 65% (N= 20/31) of the
carers, the project led to an improvement in the every-
day functioning of the patients. We also asked for spe-
cific domains of improvement (see Table 5). Most not-
ably, 80% (N=24/30) of carers affirmed a reduction in
aggressive behaviors; carers rated this improvement
more frequent among outpatients than among remittedpatients (p = .019). Other domains of functioning with
substantial improvement were social conduct in general
(67%), insight into illness (55%) and reduction of khat
use (57%).
In order to validate these general yes-no questions, we
asked carers to state every-day activities, which had
improved since the time before the project. Twenty
carers (61%; i.e. 20/33) were able to name such concrete
improvements. The notion that patients improved in
general was highly associated with mentioning any such
improved activity (Phi = .518, p = .004). On average,
carers mentioned 1.5 (SD= 1.5) such activities that were
on average each related to an improvement of function-
ing of 3.3 days per week (SD= 3.1). There were no differ-
ences between groups of patients (Table 5).
In four cases (12.5%; 2/16 outpatients vs 2/16 remitted
patients, p = 1.000) the improvements reported by carers
were substantial, whereby former patients had become
fully functional in their social environment. Three of
Table 5 Carers’ ratings of functioning improvement
All patients (35) Outpatients (17) Remitted patients (18) p1
General improvement1 64.5% (20) 70.6% (12) 57.1% (8) .477
Social behavior improvement2 66.7% (22) 76.5% (13) 56.3% (9) .218
Insight into illness improved2 54.5% (18) 47.1% (8) 62.5% (10) .373
Less aggression3 80.0% (24) 100% (14) 62.5% (10) .019
Reduced khat chewing4 57.1% (16) 66.7% (8) 50.0% (8) .378
Tolerated khat better5 51.9% (14) 66.7% (8) 40.0% (6) .168
Improved insight into dangers of khat3 26.7% (8) 21.4% (3) 31.3% (5) .689
Improved productive life6 45.5% (15) 47.1% (8) 43.8% (7) .849
Other improvement7 9.4% (3) 18.8% (3) 0 (0) .226
Caretaker states any improved every-day activity6 60.6% (20) 76.5% (13) 43.8% (7) .055
Number of improved every-day activities6 1.48 (1.46) 1.82 (1.42) 1.13 (1.45) .173
Average number of days with improved activities6 3.20 (3.07) 3.62 (2.89) 2.75 (3.28) .423
We report percentages and n (in brackets) or means and standard deviations (in brackets).
1missing data: 17 outpatients 14 remitted patients.
2missing data: 17 outpatients 16 remitted patients.
3missing data: 14 outpatients 16 remitted patients.
4missing data: 12 outpatients, 16 remitted patients.
5missing data: 12 outpatients 15 remitted patients.
6missing data: 17 outpatients, 16 remitted patients.
7missing data: 16 outpatients 16 remitted patients.
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start income-generating activities for 6 or 7 days per
week; two of them became the major income providers
of their families; another outpatient was unemployed
despite restored functioning. In his own opinion the rea-
son for this was his low educational level.
For the other patients, reported improvements were
more basic, however, still important: carers reported
that eleven patients (34.4%; 7/16 outpatients, 4/16 re-
mitted patients, p = .264) had started to help with
household or family duties, such as fetching water,
doing shopping, helping with animals or farming etc.;
the average number of days they had improved their
respective behavior at follow-up was 5.4 days per
week (SD= 1.9).
Nine patients (28.1%) normalized their basic com-
munication and socializing behavior with an average
improvement of 5.3 (2.5) days per week; in some
cases they had not spoken at all for long periods and
under medication started to interact again with their
carers. Eight of the nine patients were outpatients
(p = .015).
Seven others (21.9%; 4/16 outpatients vs. 3/16 remitted
patients, p = 1.000) had substantially improved their per-
sonal hygiene and started to care for themselves, e.g. tak-
ing a shower or using a toilet; on average number of
days with improved functioning in this domain was 6.1
(SD= 1.5).
The sum of reported improvement days were equally
distributed between outpatients and remitted patients
(p = .264)Khat use
Khat use was our third main outcome variable. In
the month before inclusion into the project, 76.5% of
outpatients and 58,8% of remitted patients had chewed
khat (Figure 3; Additional file 1 Table S2; p = .271). In the
week previous to the inclusion into the project, outpati-
ents were using khat on more days than remitted patients
(p= .013); the consumed amount in this week did not dif-
fer between the groups (p= .128), however, more excessive
users could be found among the previous. In March/April
2007 (T3), almost all remitted patients had resumed khat
chewing, more than outpatients (10/17 vs 15/16; p = .039).
While we found a reduction of khat use as categorical
variable in the course of the project among outpatients
(p= .015), no significant change could be observed among
remitted patients (p= .333). At T3, days of khat use and
amount of bundles consumed in the last week did not dif-
fer between groups (p= .460, p = .594). In repeated mea-
sures ANOVAs the time*group interaction was nearly
significant for the dependent variable khat bundles
(p= .079) and significant for days with khat use in the last
week (p= .014). In paired t-tests, the days of khat use as
well as the consumed bundles in the previous week
increased among remitted patients (p= .030, p = .016) but
did not change among outpatients (p= .192, p = .543).
Discussion
We studied and compared the feasibility and effects
of family-based acute treatment and two models of
community-based relapse-preventive outpatient care for








































































Khat bundles last week
out−patients (N = 17)
remitted patients (N = 18)
Figure 3 Khat use indicators during the project. Error bars represent percentages or means and standard deviations before enrollment and at
follow-up.
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carers accepted the project and appreciated the assistance,
as limited it was. In most cases, families worked reliably
and closely with the project. Initial exaggerated hopes
and expectations towards economic assistance could
be dealt with in the course of the project. Our out-
come variables showed a disassociation between psy-
chotic symptoms versus levels of functioning and
depression - the latter improved while the former did
not. We also found that khat use can be reduced
even among users with an addictive use pattern.
In spite of the methodological shortcomings, ourfindings demonstrate that community-based psychiatric
care in a country with almost no psychiatric resources can
improve functioning and depressive symptoms in patients
with long-term disorders living in inhumane conditions
and is therefore ethically justified. Additionally, they also
demonstrate that more stringent research is needed to
scientifically prove evidence and that concepts of
community-based mental health care need to be further
developed.
The low dose treatment with Chlorpromazine seemed
to produce a measurable improvement of the symptom
levels, especially in the acute treatment phase, and
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proved to be relatively safe in respect to medical compli-
cations and side effects.
We found that acute treatment of productive psychotic
patients in their homes where many of them were chained
is effective, i.e. acute symptom levels can be reduced to a
level comparable to patients in remission. Similar results are
known from Soteria [43] treatment approaches using low-
dose medication and home-based treatments in western
countries [44].
Concerning relapse prevention in the community, our
results go along the lines of other treatment studies show-
ing that relapse cannot be fully prevented but its risk can
be reduced even by low-dose neuroleptic treatment [45]
and that first-generation anti-psychotics can be equally ef-
fective than newer drugs [46]. Of course, due to the lack of
an untreated control group (i.e. treatment as usual), the ef-
fect of our interventions cannot be fully evaluated. Further-
more, it is a challenge to define relapse and remission in
the setting in which we operated, because we lacked a con-
tinuous presence of resources and highly trained staff who
would have been able to rate symptoms with clinical instru-
ments. For example, in the dearth of in-patient services, the
simple readmission criteria do not appropriately apply. We
reduced this question to the measurement of symptom
severity on a group basis at pre-, post and follow-up assess-
ments. We found that both positive and negative symptoms
improved during acute treatment and deteriorated again in
the course of the follow-up period. Changes of positive
symptoms from post to follow-up probably were influenced
by khat use and medication compliance. Changes of nega-
tive symptoms probably reflect the long-term course of ill-
ness as they can hardly be influenced by the medication we
used.
The data on symptom levels are opposed to the findings
on functioning: While both groups differed in their psycho-
pathological outcomes, functioning improvements occurred
on an equal base. This reflects the outcome of other re-
search that symptom severity and functioning in every-day
roles are non-congruent [47]. Only about 10% of patients
restored their functioning completely, which is still substan-
tial face to the chronic manifestation of the disorders.
About 60% of patients improved in basic dimensions of
human existence like communication, living together and
self-care. This is encouraging, as we had recruited
chronic cases with protracted course of illness.
We know that a comparison between our groups needs to
be treated with caution. But it is still necessary to discuss
several important implications resulting from the distinction
of the two treatment packages and reasons why outpatients
had less favorable symptom course but better khat-related
outcomes than remitted patients. Our results demonstrate
that medication compliance could have been better main-
tained among outpatients who had received the acutetreatment phase and a much more intensive monitoring
and psycho-education of medication use during the prevent-
ive treatment phase. This is an important selective finding
because non-compliance is one of the most important risk
factors for relapse. Also khat use among outpatients was
kept at a lower level. Only this group of patients and their
families received the intensive acute treatment phase, which
included psycho-education and assistance to reduce khat
use. According to our observations, also the focus on
psycho-education for medication during home visits in the
preventive phase also led to a more intense psycho-
education on khat effects. We also believe that the better ad-
herence to prescribed medication among outpatients can
add to the explanation of the less severe khat use in this
group. Based on the well-established pharmacological
actions of neuroleptic drugs, we can indeed assume that im-
mediate khat effects such as euphoria are dampened under
neuroleptic treatment. This might have reduced compulsive
use. Based on these results, we hypothesize that medication
compliance and khat abstinence can be positively influenced
by higher investments in psycho-education, motivational
interventions and monitoring.
Over the full project period, low symptom levels could
not be maintained with the exception of depressive
symptoms. But this symptomatic increase was more pro-
nounced in the outpatient group. This was not expected
especially because medication compliance and khat use
reductions seemed to be more successful in this group.
One potential reason for this symptomatic relapse might
be the fact that remitted patients actively maintained
contact to service providers (mostly hospital) and outpa-
tients did not. But just the simple fact that a person had
been inpatient before, might make it more likely that he/
she will search for specialist care in case of a relapse
compared to patients who had never had any contact
with inpatient treatment facilities before. Another reason
might be that our recruitment has produced two groups
with a-priori differences. Remitted patients and their
families might have lived in better economic situation,
had a better formal education, had more knowledge on
schizophrenia and its treatment, might have a more
western concept of the disorder or even a higher family
support or sense of responsibility compared to outpati-
ents [17]. It is difficult to detect potential a-priori differ-
ences based on our data. On the one hand, we found no
difference concerning the indicators of economic situ-
ation and education, but we did find more in-patient
treatments, less chaining and restraining and less mal-
nourishment among the patients of the remitted group.
These differences possibly reflect poorer care, more
stress and inhumane practices, a more chronic and se-
vere course of illness, a higher sensitivity to khat effects
and a later start of treatment after illness onset in the
outpatient group. These potential differences and their
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as relapse has high costs to patients and families [48]
and its prevention is the most important goal in the
post-acute treatment phase, future research will need to
study the question explicitly which relapse prevention
treatment model is the more favorable in a given
situation.
Our findings also demonstrate the complex effects of
khat use on psychotic outcomes. According to our data
and observation, khat use in the acute phase of treatment
had a high positive association to the severity of florid
symptoms of psychosis. This result replicates the findings
reported in the literature that khat use can induce psych-
otic symptoms or cause exacerbation of pre-existing
psychotic disorders [29]. According to our observations,
we had managed to motivate outpatients in the first six
weeks of the study to stop consuming khat almost com-
pletely; this is comparable to the in-patient treatment
where patients are not given access to khat. Abstinence is
likely to have supported initial treatment effects. However,
in the post-acute relapse prevention treatment, this associ-
ation between khat and symptoms unfolded in more com-
plex interactions. Abstinence motivation of patients and
carers eroded in the course of the follow-up period and
most patients had returned to khat chewing in the course
of the 10 months. But khat use correlated at this point of
time inversely with positive psychotic symptoms, i.e. when
patients felt well and functioned satisfactory they chewed
more khat. These at first sight contradictory correlations
may be explained, by the fact that the amount of khat use
by a single patient varies greatly over time in a very dy-
namic system. Factors in this system that increase khat
use are addiction and the fact that khat is a common and
integral part of social life in the Somali culture. These two
factors probably explain why patients restart khat use after
remission, i.e. when patients are less psychotic they chew
more khat. Factors that decrease khat chewing are exter-
nal restrictions of access to khat through measures like
hog-tying and the desire of the patient to stop khat use.
Indeed, we found anecdotal evidence that khat use after
remission is noxious and might constitute a risk factor for
relapse, because families re-chained patients to restrict
khat use when they observed that their psychosis symp-
toms worsened. This is supported by other studies [32].
Thus, from an ethical perspective, a clinician needs to as-
sume that continuous khat use is a risk factor for a psych-
otic relapse and has to recommend that khat use is
discontinued because even small amounts might be nox-
ious. In this context khat needs to be seen as part of the
repeated cycle of relapse and remission, chaining and
unchaining of patients. This also demonstrates that the in-
terpretation of an isolated correlation between khat use
and psychosis based on data from one single point in time
is not meaningful to describe the underlying complexrelationship. Antipsychotic medication may help patients
to maintain social and occupational functioning and may
assist to tolerate consumption within an acceptable range,
e.g. by taking the medication in the evening to promote
sleep at night. The influence on khat on repeated relapses
needs to be explicitly better understood in order to design
targeted interventions. Our results also show that short-
term intervention strategies to address khat abuse are of
limited effect. Our data show that khat addiction is very
frequent among psychotic patients and that community-
based health services will probably only be effective when
its therapy is integral part of the treatment package.
Therefore, culturally adequate interventions to address
khat addiction urgently need to be developed.
But among users without pre-existing mental disorder
khat consumption might actually range from severe
abuse with potentially disastrous health effects to more
controlled and moderate use patterns that are not or less
harmful and that go hand in hand with social integra-
tion. The current study was not designed to empirically
determine the dynamic boundary between noxious and
harmless khat use; future studies are needed to clarify
this important question. The difference between noxious
and non-noxious khat use probably depends on the
amount and hours of use per day, maintaining night
sleep, regular food intake etc., all points that need to be
explicitly addressed in future studies. According to our
anecdotal observations, harmful consequences of khat
use among healthy individuals often occur when con-
suming for several weeks beyond normal amounts (one
to two bundles) per day, chewing continuously for more
than the culturally sanctioned period of 3 to 5 afternoon
hours a day. The consequent inversion of sleeping pat-
terns can be a warning sign of noxious effects on health.
In our work with psychotic patients and their carers in
Somalia we observed the common experience of a very
severe stigmatization due to mental illness. Patients and
carers were excluded and stigmatized in their families
and communities and were often abandoned, isolated
and impoverished. We, thus, tried to make them feel
accepted as valuable members of their communities.
The psycho-social assistance turned out to be a vital
component of the project intervention. Carers carry a
heavy emotional, social and financial burden caring for
their mentally ill. Often they reported that the home vis-
its and conversations with project staff were helpful be-
cause they found someone to talk to about their stress
and thus felt relief. These conversations could then be
extended to inform patients and their carers so that they
accepted medical recommendations concerning treat-
ment and especially the advice to reduce khat intake.
Our pilot study has a number of limitations. First, our
design did not include a control group who received treat-
ment as usual which would have enabled to evaluate the
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patients entered the study at different points in time; it
would have been a great opportunity to recruit one group
at hospital intake instead of discharge; this would have
made it possible to know whether groups of patients were
different before inclusion into the project. In the current
project, we probably have compared groups of patients
with different a-priori characteristics and courses of symp-
toms. In future studies, it would be also desirable to in-
clude groups of patients without khat abuse and to
dismantle effects of different components of the delivered
treatment package (i.e. one group without psycho-social
interventions). Second, our treatment delivery was also
determined by attempts to test feasibility and sustainabil-
ity rather than current standards of treatment, e.g. using
Chlorpromazine and Haloperidol instead of second-
generation antipsychotics and using low-dose treatment in
all cases - also for those who would have been profited
more from higher dosages. However, we followed the
WHO guidelines that had been applied in different set-
tings at that time and that were recently published [42].
Third, our treatment packages did not contain important
components that are standard in High-Income Countries
such as occupational therapy or self-help groups. Self-help
groups in LMICs can assist patients and carers to improve
social and economic hardships and reduce exclusion and
stigmatization in the community [49]. Another challenge
that was not addressed in our pilot project is the reintegra-
tion of patients into productive life. This might be especially
problematic for poorly trained and economically disadvan-
taged families who constituted the large majority in the
present project. Thus, occupational therapy, vocational
training and the build-up of income-generating activities
on the family level might have helped with the patient’s
symptomatic and functional recovery, reduce stigmatization
and improve the family’s economic situation. Finally, based
on our design and assessment in this sample of patients
with chronic psychotic disorder we were not able to deter-
mine the exact diagnosis of patients, i.e. whether it was
schizophrenia, other long-term psychotic disorders or long-
term substance-induced psychotic disorder. In stead, we
have focused on selected DSM IV criteria for schizophrenia
(characteristic symptoms, social/occupational dysfunctions,
duration) to ensure the existence of a long-term psychotic
disorder. We believe that the exact diagnosis is not neces-
sary in the context of this study.
Despite limitations this study demonstrates compo-
nents of effective family-based and outpatient treatment
for patients with chronic psychotic disorders in Somalia,
where khat abuse among patients is rather the rule than
the exception. From a pragmatic point of view, future
projects should consider the combination of home visits
with psycho-social support and delivery of medication as
well as establishing and maintaining contact of thefamilies to the existing in-patient services for referral in
case of severe relapses. An inclusion of a self-help as
well as an income-generating component for the
patients and their families need to be considered because
the families live in extreme poverty without much hope
to improve their situation and be able to sustain a neces-
sary treatment by own means. Such components might
be included during the post-acute treatment phase and
should be directed towards patients and their carers.
Also patients’ khat addiction must be addressed and con-
sumption be regulated to prevent relapses. Currently there
are no evaluated treatment concepts for khat addiction.
Conclusions
Based on this pilot study, we conclude that despite chal-
lenges related to limited local capacities, a reliance on
first-generation antipsychotics, despite the missing con-
tinuous supervision by trained psychiatrists and despite
co-morbid khat abuse, a community-based outpatient
mental health treatment is feasible and well accepted
under the resource-poor conditions of Somalia. And it
shows effective pre to post changes in real-world out-
come. Facing the dearth of mental health services and
the abundance of inhumane treatment of patients with
long-term mental disorders, we conclude that, in spite of
the lack of a control group and other methodological
shortcomings in this study, community-based treatment is
ethically imperative. The key to success of community-
based psychiatric intervention seems the trusting relation-
ship of project staff to patients and their carers. This can
be established through regular home visits, which provide
psycho-social support to patients and carers, which
allowed for repeated monitoring and education on psych-
osis and its treatment as well as the dangers of khat abuse.
Due to the reliance on locally available drugs and
resources, the costs of the initiated treatments are low in
the post-acute phase of treatment. But the extreme pov-
erty prevents that even very cheap treatments be sustained
by a large part of the involved families. This problem
needs to be addressed by additional income-generating
components.Additional file
Additional file 1: Table S1. Medication side effects at follow-up. The
table reports means and standard deviations as well as percentages and N.
Results of group comparisons between outpatients and remitted patients
are reported in the last column. 1 missing data: 16 outpatients, 13 remitted
patients. 2 missing data: 17 outpatients, 12 remitted patients. Table S2: Khat
use indicators during the project. We report percentages and N or means
and standard deviations before enrollment and at follow-up. 1 missing data:
15 outpatients, 17 remitted patients (10 discharged, 7 community). 2
missing data: 13 outpatients, 16 remitted patients (9 discharged, 7
community). 3 missing data: 16 outpatients, 16 remitted patients (9
discharged, 7 community). 4 missing data: 17 outpatients, 16 remitted
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http://www.ijmhs.com/content/6/1/8patients (10 discharged, 6 community). 5 missing data: 16 outpatients, 16
remitted patients (10 discharged, 6 community).
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